Neurosense Therapeutics Ltd

Market Cap

$31M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.75-$0.03 (-3.82%)

Jun 5, 2026

52W High $2.4952W Low $0.69

Company Details

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead produ...

CEO

—

IPO Date

Dec 9, 2021

Website

www.neurosense-tx.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$9M

EPS (Diluted)

Free Cash Flow

-$4.0K

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Jun 22, 2026

PENDING

FY 2025

Mar 31, 2026

Q2 2025

Aug 1, 2025

Q1 2025

Apr 7, 2025

FY 2024

Dec 31, 2024

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding